Annual CFO
-$30.11 M
+$3.97 M+11.66%
30 June 2024
Summary:
Renalytix annual cash flow from operations is currently -$30.11 million, with the most recent change of +$3.97 million (+11.66%) on 30 June 2024. During the last 3 years, it has fallen by -$5.48 million (-22.24%). RNLX annual CFO is now -389.13% below its all-time high of -$6.16 million, reached on 30 June 2019.RNLX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
N/A
30 September 2024
Summary:
Renalytix quarterly cash flow from operations is not available.RNLX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
N/A
30 September 2024
Summary:
Renalytix TTM cash flow from operations is not available.RNLX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | - | - |
| 3 y3 years | -22.2% | - | - |
| 5 y5 years | -389.1% | - | - |
RNLX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.2% | +34.4% | ||||
| 5 y | 5 years | -389.1% | +34.4% | ||||
| alltime | all time | -389.1% | +34.4% |
Renalytix Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$30.11 M(-11.7%) | -$7.83 M(+58.5%) | -$30.11 M(-2.6%) |
| Mar 2024 | - | -$4.94 M(-37.0%) | -$30.92 M(-14.5%) |
| Dec 2023 | - | -$7.84 M(-17.5%) | -$36.15 M(-0.9%) |
| Sept 2023 | - | -$9.50 M(+10.1%) | -$36.47 M(+7.0%) |
| June 2023 | -$34.09 M(-25.8%) | -$8.63 M(-15.1%) | -$34.09 M(-14.0%) |
| Mar 2023 | - | -$10.17 M(+24.6%) | -$39.62 M(+8.6%) |
| Dec 2022 | - | -$8.16 M(+14.6%) | -$36.47 M(-14.3%) |
| Sept 2022 | - | -$7.12 M(-49.7%) | -$42.55 M(-7.3%) |
| June 2022 | -$45.92 M | -$14.17 M(+101.7%) | -$45.92 M(+38.8%) |
| Mar 2022 | - | -$7.02 M(-50.7%) | -$33.09 M(+7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$14.24 M(+35.8%) | -$30.79 M(+24.6%) |
| Sept 2021 | - | -$10.49 M(+688.7%) | -$24.71 M(+0.3%) |
| June 2021 | -$24.63 M(+158.7%) | -$1.33 M(-71.9%) | -$24.63 M(-4.1%) |
| Mar 2021 | - | -$4.73 M(-42.1%) | -$25.69 M(+8.4%) |
| Dec 2020 | - | -$8.16 M(-21.6%) | -$23.69 M(+29.7%) |
| Sept 2020 | - | -$10.41 M(+336.3%) | -$18.26 M(+91.7%) |
| June 2020 | -$9.52 M(+54.7%) | -$2.39 M(-12.4%) | -$9.52 M(+33.5%) |
| Mar 2020 | - | -$2.73 M(-0.2%) | -$7.13 M(+61.8%) |
| Dec 2019 | - | -$2.73 M(+62.5%) | -$4.41 M(+162.5%) |
| Sept 2019 | - | -$1.68 M | -$1.68 M |
| June 2019 | -$6.16 M | - | - |
FAQ
- What is Renalytix annual cash flow from operations?
- What is the all time high annual CFO for Renalytix?
- What is Renalytix annual CFO year-on-year change?
- What is the all time high quarterly CFO for Renalytix?
- What is the all time high TTM CFO for Renalytix?
What is Renalytix annual cash flow from operations?
The current annual CFO of RNLX is -$30.11 M
What is the all time high annual CFO for Renalytix?
Renalytix all-time high annual cash flow from operations is -$6.16 M
What is Renalytix annual CFO year-on-year change?
Over the past year, RNLX annual cash flow from operations has changed by +$3.97 M (+11.66%)
What is the all time high quarterly CFO for Renalytix?
Renalytix all-time high quarterly cash flow from operations is -$1.33 M
What is the all time high TTM CFO for Renalytix?
Renalytix all-time high TTM cash flow from operations is -$1.68 M